The Brain Protection Company Awarded $1M Research Grant To Pur... - 25 August 2020 15:31

SYDNEY, Aug. 25, 2020 /PRNewswire-AsiaNet/ -- The Brain Protection Company Pty Ltd, a privately-held medical device company developing novel therapies and diagnostics for Alzheimer's disease, today announced it has been awarded a US$1 million grant from the Part the Cloud - Bill Gates Partner...

  One Drop Announces Nearly $100M Financing And Commitments By B... - 24 August 2020 21:00

NEW YORK, Aug. 24, 2020 /PRNewswire-AsiaNet/-- -- $98.7M financing, development fees and commercial milestone commitments accelerate the development and commercialization of One Drop's digital health platform and data-driven predictive capabilities across multiple therapeutic areas One Drop...

  US FDA Awards Orphan Drug Designation (ODD) To Paxalisib For M... - 24 August 2020 12:05

SYDNEY, Aug. 24, 2020 /PRNewswire-AsiaNet/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Kazia's paxali...

  Cognitive Behavioural Therapy Market by Current Industry Statu... - 24 August 2020 10:00

PUNE,India, August 24 /PRNewswire-AsiaNet/ -- - The global cognitive behavioural therapy market was valued at US$ 2152.47 Mn in 2018 and is anticipated to grow at a CAGR of 5.06% over the forecast period. (2019 – 2027) - Governmental agencies across the world are creating awareness about ...

  Cipla and Stempeutics collaborate for launch of Stempeucel(R),... - 21 August 2020 06:00

MUMBAI, India, August 21 /PRNewswire-AsiaNet/ -- - First approved allogeneic cell therapy product globally for the treatment of CLI - Developed by Stempeutics over a period of twelve years, breakthrough treatment designed to address root cause of the disease at an affordable cost - Cipla t...

  LumiraDx Receives FDA Emergency Use Authorization for Point of... - 20 August 2020 20:00

LONDON, Aug. 20, 2020 /PRNewswire-AsiaNet/ -- LumiraDx ( https://c212.net/c/link/?t=0&l=en&o=2891881-1&h=207010375&u=https%3A%2F%2Fwww.lumiradx.com%2Fus-en%2F&a=LumiraDx ), the next-generation point of care diagnostic company, announced today that it has received Emergency Use Authorization (...

  Higher Logic Australia Has Grown its Customer Base by Over 250... - 20 August 2020 11:49

SYDNEY, Aug. 20, 2020 /PRNewswire-AsiaNet/ -- - Through the COVID-19 pandemic, Higher Logic customers have seen notable increases—seeing over a 300% increase in new logins and almost 500% increase—in community engagement. Higher Logic, the industry-leading, human focused engagement platfor...

  US FDA Awards Fast Track Designation (FTD) to Paxalisib for Gl... - 20 August 2020 11:09

SYDNEY, Aug. 20, 2020/PRNewswire-AsiaNet/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kazia's paxalis...

  Zymo Research Granted CE IVD Mark for Quick SARS-CoV-2 rRT-PCR... - 20 August 2020 10:22

IRVINE, California, Aug. 20, 2020 /PRNewswire-AsiaNet/ -- Zymo Research announced that it was recently granted the CE IVD Mark for its Quick SARS-CoV-2 rRT-PCR Kit. To obtain this certification the product had to comply with the Directive 98/79/EC of the European Parliament and of the Council of 27 Octob...

  Global Death Care Services Market Analysis - Global Industry S... - 19 August 2020 11:00

PUNE, India, August 19, 2020 /PRNewswire-AsiaNet/ -- - China death care services market was valued at US$ 16.39 Bn in 2017 and is anticipated to witness a compound annual growth rate of 11% over the forecast period, owing to the substantial increase in mortality rate. Request for Sample...